Will ‘Transformative’ UK Life Sciences Sector Deal Help Offset The Brexit Effect?
Executive Summary
The UK government has published its life sciences sector deal, which it says will allow the UK to respond to the challenges and opportunities of demographic change and pioneering research and development – although there is no mention of the “Brexit effect.”
You may also be interested in...
R&D Model Needs ‘Radical Reshaping,’ Says UK Report
A new report has identified a number of ways to boost the productivity of drug research and development at small and medium-sized companies, including new R&D tools and models, more collaborative approaches and better use of the huge amounts of data being generated.
Izana Bioscience Set Up For Ankylosing Spondylitis Breakthrough
A new UK company set up by entrepreneur Bryan Morton to develop an innovative medicine for ankylosing spondylitis may be an example of how start-up companies could be supported through the UK's just announced industrial strategy for the life sciences sector.
Sir John Bell: UK Life Science Pact Essential For Post-Brexit Success
Successfully piecing together the agreed life sciences sector deal calls for the UK to embrace high-risk innovation and placing the NHS at its center, says Sir John Bell who helped formulate the pact.